Empagliflozin/Metformin Tablet 5/1000 mg
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
MFDS item code 202201384 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes
This medication is used in conjunction with dietary and exercise therapy to assist patients with type 2 diabetes in controlling their blood sugar levels. It is particularly recommended for adults whose blood sugar control is insufficient with existing treatments. Additionally, it is important for patients with type 2 diabetes who have cardiovascular disease to refer to expert guidance when using this medication. Overall, this medication is used to effectively control blood sugar levels to aid in the management of diabetes.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Contraindications, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication can cause a rare but serious side effect known as severe lactic acidosis, so special caution is needed for patients with impaired kidney function or heart disease. When used in conjunction with other antidiabetic agents, there may be an increased risk of hypoglycemia, so blood sugar changes should be closely monitored. Patients with moderate or severe kidney impairment or conditions that may cause acute kidney injury should not take this medication. Dosing should be temporarily suspended around surgical procedures or during serious infections or dehydration, and resumed only once the condition stabilizes. Pregnant or breastfeeding women should not take this medication, and women of childbearing potential should consult healthcare providers before use. This medication may increase the risk of urinary tract infections and genital infections, so medical attention should be sought immediately if infection symptoms appear. It is vital to monitor kidney function and vitamin B12 levels through regular blood tests during treatment, and appropriate treatment is necessary if vitamin B12 deficiency is suspected. Elderly patients or those at risk of fluid loss should pay close attention to hydration and changes in condition due to potential dehydration and low blood pressure. Alcohol consumption can increase the risk of lactic acidosis, so it is advisable to avoid drinking during treatment. Patients taking this medication should be cautious of potential interactions with other drugs, and should always consult healthcare providers before starting or stopping any new medications. Severe side effects can occur in cases of overdose, so strict adherence to the dosage is essential, and immediate medical attention should be sought at the onset of any unusual symptoms. The safety and effectiveness of this medication in children have not been established, so it is not recommended for those under 18 years of age. Store this medication out of reach of children and keep it in its original container to maintain quality. Patients taking this medication should exercise caution when driving or operating machinery, as hypoglycemic symptoms may occur and immediate action should be taken if symptoms arise.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.
Brown-yellow, film-coated, oval-shaped tablets with a convex surface on both sides
10 tablets/box [(10 tablets/PTP X 1)], 60 tablets/box [(10 tablets/PTP X 6)], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.